Drug Discovery & Development

News on drug screening, clinical trials, companion diagnostics, immunotherapy, & personalized therapies in genetics, genomics, and molecular diagnostics.

Macrogen, Exosome Plus Ink MOU, Deal for Exosome Isolation Kits

The South Korean companies have also agreed to work together on the development of exosome-based biomedical products including diagnostics and therapeutics.

Roche Partners with Biognosys, Caprion to Demonstrate Proteomics Readiness for Clinical Trials

Premium

Roche ran a mock clinical trial in which it used DIA mass spec and targeted proteomics to profile 30 colorectal cancer samples under GCP conditions.

Twist Bioscience Providing Antibody Optimization to Pandion Therapeutics for Drug Development

The partnership follows a strategic collaboration between Twist and LakePharma, announced last week, that involves the same technology.

Evotec, Indivumed Partner on Colorectal Cancer Drug Discovery

Evotec will access Indivumed's IndivuType multi-omics cancer database to discover and develop new precision therapeutics for colorectal cancer.

Project GENIE Used to Explore Impact of Rare Cancer Mutations on Treatment Response

Premium

Studies presented at the AACR meeting demonstrated how the registry can be used to evaluate how cancer patients with rare tumor markers respond to treatments.

Apr 01, 2019

Bayer, Loxo Next-Generation TRK Inhibitor Shows Promising Activity in AACR Study

Premium

Mar 31, 2019

CAR-T Cell Therapies Targeting HER2, Mesothelin Show Activity in Solid Tumors

Premium

Mar 21, 2019

Dalcor Holds Firm on Plans for Dalcetrapib Despite Negative Merck Results

Premium

Mar 14, 2019

AstraZeneca's Acoustic Mist Mass Spec Platform Can Run 100K Samples Daily

Premium

Mar 04, 2019

Colon Cancer Patients Could Benefit From HER2 EGFR Non-Response Findings, Investigators Say

Premium

Feb 27, 2019

Danaher Prices $2.76B Offering of Common, Preferred Stock

Feb 14, 2019

AbCellera, Novartis Partner on Antibody Drug Discovery

Feb 08, 2019

Lonza to Sell AllCells Hematopoietic Primary Cell Products

Feb 08, 2019

Twist Bioscience Grows SynBio Business, Invests in NGS While Battling Agilent Lawsuit

Premium

Feb 05, 2019

Arivale Partners to Mine Growing Customer Data for Rx, Dx Insights

Premium

Feb 01, 2019

Antimicrobial Candidate Found in Insect Microbiome Analysis

Jan 29, 2019

Sphere Fluidics Closes $2M Financing Round

Jan 18, 2019

Sphere Fluidics, Peak Analysis Partner for Single-Cell Analysis

Jan 04, 2019

Adaptive Biotechnologies, Genentech Form Personalized Cancer Therapy Partnership

Dec 20, 2018

Twist Bioscience to Open Manufacturing Facility in China; Sees Strong Demand for NGS Products

Premium

Dec 20, 2018

Bayer, HitGen Partner on Small Molecule Discovery for Crop Science

Dec 19, 2018

Celmatix Forms Therapeutics Discovery Division

Dec 18, 2018

Bristol-Myers Squibb, Boston Medical Center Partner to Study Immuno-Oncology Response, Resistance

Dec 18, 2018

OncoImmunity Wins €2.2M in European Funding for Neoantigen Prediction Tech

Dec 17, 2018

Bristol-Myers Squibb, H3 Biomedicine Form Cancer Immunotherapy Alliance

The Scan

Bill to Ease Post-Conviction DNA Testing Access

The Oregon state Senate unanimously passed a bill that would make it easier for people convicted of crimes to initiate DNA testing of evidence, according to the Associated Press.

Ah, Feel Full Now

People reports that researchers have uncovered genetic variants that lead people to always feel full.

Life Insurers, Too, in Florida?

Florida state senators are to weigh a bill prohibiting life insurance companies from using genetic information in coverage decisions, according to Florida Politics.

This Week in Genome Research

In Genome Research this week: metagenomic sequencing assay that detects pathogens in cerebrospinal fluid, single-tube long fragment read approach, and more.

Featured White Papers

NGS is Accelerating Therapeutic Antibody Discovery - What Lies Beyond?

Powerful Bioinformatic Support for Specialized Therapeutic Antibody Discovery

How to Use CrownBio's Integrated Oncology Portfolio for Target Identification and Mechanism of Action Elucidation

Immuno-Oncology: 3 Strategies for Applying Humanized Models

May

08

Featured Webinar

OncoBEAM ctDNA Testing for Early Response Prediction and Therapy Surveillance in Melanoma and Pancreatic Cancer

This webinar will present recent evidence that demonstrates how incorporating circulating tumor DNA (ctDNA) assessments into real-world patient management can influence patient care decisions, alter radiographic interpretations, and impact clinical outcomes.

Jun

25

Featured Webinar

Menu

Drug Discovery & Development

What's Popular?

Sponsorships